Mutants of bone morphogenetic proteins
AssigneeGenetics Institute, Inc.
InventorsNeil M. Wolfman, John McCoy
Life of this patent
Estimating the term…
Abstract
DNA molecules encoding mutant forms of bone morphogenetic proteins (BMP) are disclosed, The mutant forms of BMP can be produced bacterially and refolded to produce biologically active homodimers or heterodimers of BMP. A method of making such mutant BMPs is also disclosed.
Claims12
A recombinant DNA molecule comprising a nucleotide sequence encoding BMP-4 as shown in SEQ ID NO:3, except that the nucleotide triplet at 319 to 321 has been replaced with a triplet encoding aspartic acid.
A recombinant DNA molecule comprising a nucleotide sequence encoding BMP-5 as shown in SEQ ID NO:5, except that the nucleotide triplet at 166 to 168 has been replaced with a triplet encoding histidine.
A recombinant DNA molecule comprising a nucleotide sequence encoding BMP-6 as shown in SEQ ID NO:7, except that the nucleotide triplet at 166 to 168 has been replaced with a triplet encoding histidine.
A recombinant DNA molecule comprising a nucleotide sequence encoding BMP-7 as shown in SEQ ID NO:9, except that the nucleotide triplet at 187 to 189 has been replaced with a triplet encoding histidine.
A purified mutant BMP-4 comprising the amino acid sequence of SEQ ID NO:4, wherein the glutamic acid at amino acid residue 107 has been replaced with aspartic acid.
A purified mutant BMP-5 comprising the amino acid sequence of SEQ ID NO:6, wherein the alanine at amino acid residue 56 has been replaced with histidine.
A purified mutant BMP-6 comprising the amino acid sequence of SEQ ID NO:8, wherein the alanine at amino acid residue 56 has been replaced with histidine.
A purified mutant BMP-7 comprising the amino acid sequence of SEQ ID NO:10, wherein the alanine at amino acid residue 63 has been replaced with histidine.
Dependencies are inferred from the claim text.